82 related articles for article (PubMed ID: 9437218)
1. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
[TBL] [Abstract][Full Text] [Related]
2. The management of thyroid cancer in adults: a review of new guidelines.
Harris PE
Clin Med (Lond); 2002; 2(2):144-6. PubMed ID: 11991098
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 2A syndrome presenting with corneal nerve thickening.
Petrie I; Knox Cartwright N; Roberts H; Kyrodimou E; Moudiotis C; Owens M; Cleaver R; Smith J; Vaidya B
QJM; 2024 Mar; 117(3):226-228. PubMed ID: 37966915
[No Abstract] [Full Text] [Related]
4. SEOM clinical guidelines for the treatment of thyroid cancer.
Martínez Trufero J; Capdevilla J; Cruz JJ; Isla D
Clin Transl Oncol; 2011 Aug; 13(8):574-9. PubMed ID: 21821493
[TBL] [Abstract][Full Text] [Related]
5. CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.
Fard N; Schlemmer HP; Raue F; Jobke B
PLoS One; 2019; 14(2):e0212865. PubMed ID: 30817772
[TBL] [Abstract][Full Text] [Related]
6.
Malhotra C; Jain AK; Thapa B; Sahu S
Middle East Afr J Ophthalmol; 2016; 23(4):326-328. PubMed ID: 27994400
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis.
Vainas I; Marthopoulos A; Chrisoulidou A; Raptou K; Tziomalos K; Pazaitou-Panayiotou K
Hippokratia; 2013 Jul; 17(3):246-51. PubMed ID: 24470736
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A.
Tang KL; Lin Y; Li LM
World J Surg Oncol; 2014 Jan; 12():8. PubMed ID: 24400812
[TBL] [Abstract][Full Text] [Related]
9. A family presenting with multiple endocrine neoplasia type 2B: A case report.
Majidi M; Haghpanah V; Hedayati M; Khashayar P; Mohajeri-Tehrani MR; Larijani B
J Med Case Rep; 2011 Dec; 5():587. PubMed ID: 22185228
[TBL] [Abstract][Full Text] [Related]
10. A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype.
Ohyama T; Sato M; Murao K; Kittaka K; Namihira H; Matsubara S; Imachi H; Yamauchi K; Takahara J
Endocrine; 2001 Jul; 15(2):143-6. PubMed ID: 11720239
[TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
13. [Diagnosis and therapy of medullary thyroid carcinoma].
Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
[No Abstract] [Full Text] [Related]
14. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
Heshmati HM; Hofbauer LC
Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
[No Abstract] [Full Text] [Related]
15. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
